EUVIMEDEUVIMED entdecken
Crossref

Targeted Next-Generation Sequencing for the Diagnosis of Gene Variants in Patients with 46,XY Disorder of Sex Development

Qiang Guo, Wen Wen Zhong, Hua Jian Lai, Lei Ye, Yi Fei Zhang, Jun Tao Li, Jian Guang Qiu, De Juan Wang

Sexual Development · 2023

DOI: 10.1159/000528916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sexual Development, 2023. Verfasst von Qiang Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Sixth Affiliated Hospital , Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Disorder of Sex Development, 46,XY. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Disorders of sex development (DSDs) are congenital abnormalities in which chromosomal, gonadal, and anatomical sex development are atypical. One of these disorders, 46,XY DSD, is particularly difficult to diagnose and manage because its etiology and clinical phenotypes are highly heterogeneous.

Methods

We used a gene panel containing 141 genes implicated in DSDs to perform targeted next-generation sequencing (NGS) in 50 patients with 46,XY DSD.

Results

Gene variants were detected in 23 patients (46%). Among them, 13 patients had previously reported pathogenic or likely pathogenic variants, 9 patients had novel variants, and 1 patient had a previously reported variant of uncertain significance. Three of the novel variants were pathogenic, and the remaining were variants of uncertain significance; therefore, 16 patients had pathogenic or likely pathogenic variants according to ACMG guidelines, and the overall diagnostic rate of 46,XY DSD was 32%. The most common gene variants were SRD5A2 variants, followed by the AR variant. In addition, we analyzed the association between gene variants and clinical phenotypes. Most patients presented with multiple DSD phenotypes (i.e., two or more DSD phenotypes were observed, such as micropenis, hypospadias, and cryptorchidism), but the phenotype with the highest diagnostic rate was micropenis.

Conclusion

Our results indicate that targeted NGS can effectively detect pathogenic gene variants in patients with 46,XY DSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disorder of Sex Development, 46,XYMutationGenital Diseases, MalePhenotypeHumansSexual Development3-Oxo-5-alpha-Steroid 4-DehydrogenaseMembrane ProteinsHigh-Throughput Nucleotide SequencingMalePenis

Stichwörter der Autor:innen

46,XY disorders of sex developmentEtiologic diagnosisGene variationsTargeted next-generation sequencing

Substanzen

SRD5A2 protein, humanMembrane Proteins3-Oxo-5-alpha-Steroid 4-Dehydrogenase

Autor:innen und Institutionen

  • Department of Urology, The Sixth Affiliated Hospital , Sun Yat-sen University, Guangzhou, China.

Zitieren

APA

Guo, Q., Zhong, W. W., Lai, H. J., Ye, L., Zhang, Y. F., Li, J. T., Qiu, J. G., & Wang, J. (2023). Targeted Next-Generation Sequencing for the Diagnosis of Gene Variants in Patients with 46,XY Disorder of Sex Development. Sexual Development. https://doi.org/10.1159/000528916

Vancouver

Guo Q, Zhong WW, Lai HJ, Ye L, Zhang YF, Li JT, et al. Targeted Next-Generation Sequencing for the Diagnosis of Gene Variants in Patients with 46,XY Disorder of Sex Development. Sexual Development. 2023. doi:10.1159/000528916

BibTeX
@article{Guo2023,
  author = {Guo, Qiang and Zhong, Wen Wen and Lai, Hua Jian and Ye, Lei and Zhang, Yi Fei and Li, Jun Tao and Qiu, Jian Guang and Wang, De Juan},
  title = {Targeted Next-Generation Sequencing for the Diagnosis of Gene Variants in Patients with 46,XY Disorder of Sex Development},
  journal = {Sexual Development},
  year = {2023},
  doi = {10.1159/000528916}
}
Kostenlos starten →